Cytosorbents (NASDAQ:CTSO) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research report released on Wednesday. The brokerage issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital restated a “buy” rating and set a $10.00 target price on shares of Cytosorbents in a research report on Tuesday, February […]
StockNews.com assumed coverage on shares of Cytosorbents (NASDAQ:CTSO – Free Report) in a research report released on Wednesday. The brokerage issued a hold rating on the medical research company’s stock. Separately, D. Boral Capital restated a “buy” rating and set a $10.00 target price on shares of Cytosorbents in a research report on Tuesday, February […]
